Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05664841 · ClinicalTrials.gov registry record · Phase 2
The Impact of a Virtual Magic Trick Training Program
A Phase 2 study of Autism and Pervasive Developmental Disorder, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05664841 is a Phase 2 study of Autism and Pervasive Developmental Disorder that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 60 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05664841, a Phase 2 study of Autism and Pervasive Developmental Disorder, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed project will attempt to confirm the benefits of a structured magic trick training program (MTTP) experience in adolescents with autism. Benefits of participating in a 6-week virtual MTTP will be evaluated using validated assessments to measure social-emotional competencies.
Conditions Studied
Interventions
- BEHAVIORAL magic trick training
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-03-27 |
| Est. Completion | 2028-02-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05664841
The ClinicalTrials.gov registry entry for NCT05664841 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 104 other Autism trials with a reported enrollment target (67% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which magic trick training is the first listed.
NCT05664841 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT05664841 about?
NCT05664841 is a clinical study titled "The Impact of a Virtual Magic Trick Training Program". The proposed project will attempt to confirm the benefits of a structured magic trick training program (MTTP) experience in adolescents with autism. Benefits of participating in a 6-week virtual MTTP will be evaluated using validated assessments to measure social-emotional competencies.
What is the current status of trial NCT05664841?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2023-03-27. Estimated completion is 2028-02-01.
What conditions does trial NCT05664841 study?
This clinical trial studies the following conditions: Autism, Pervasive Developmental Disorder.
What interventions are being tested in trial NCT05664841?
The interventions under investigation include: magic trick training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05664841?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05664841 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimizing Outcomes for Young Autistic Children
RECRUITING · Phase 2
-
Trial of Zolpidem for Sleep in Children With Autism
RECRUITING · Phase 2
-
A Study of Esomeprazole in Children With Autism
RECRUITING · Phase 2
-
Trial of Diphenhydramine for Sleep in Children With Autism
RECRUITING · Phase 2
-
Trial of Suvorexant for Sleep in Children With Autism
RECRUITING · Phase 2
-
Trial of Cannabidiol to Treat Severe Behavior Problems in Children With Autism
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.